ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of…

By E. Braunwald, E. Antman, John W Beasley, Robert M. Califf, M. D. Cheitlin, Judith Hochman, Robert H. Jones, D. Kereiakes, Joel Kupersmith, T. Levin and 13 more. Journal of the American College of Cardiology, 2002

1,489 citations recorded by the source corpus.

Subfields: Marketing

View Paper: https://www.semanticscholar.org/paper/223fcc19b392d2e83ff0be826862cd49708c66db

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Deepak L. Bhatt
F. Neumann
Gregg Stone
G. Montalescot
S. King
C. Cannon
R. Mehran
E. Braunwald

Citations in the corpus

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. (2005, background): “Abciximab is in fact unnecessary for patients treated with a non-invasive strategy.(221,273) If cardiac catheterization is unlikely to be performed within 2.”
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. (2006, background): “being implemented throughout the world.(13) The REACH Registry demon-”
Impact of medication therapy discontinuation on mortality after myocardial infarction. (2006, background): “In GRACE, variables including history of hypertension, history of heart failure, acute coronary syndrome presentation with MI compared with unstable angina, and care provided by cardiologists compared with nonspecialists were associated with medication use 6 months after MI.8 In contrast to prior st”
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention (2006, methodology): “Prior CABG (Level of Evidence: A) Added to maintain consistency with the ACC/AHA 2002 Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Myocardial Infarction (37).”